The future of unrelated Stem Cell Transplant in the UK: DOH Working Party Findings. Prof. Tony Pagliuca

Size: px
Start display at page:

Download "The future of unrelated Stem Cell Transplant in the UK: DOH Working Party Findings. Prof. Tony Pagliuca"

Transcription

1

2 The future of unrelated Stem Cell Transplant in the UK: DOH Working Party Findings Prof. Tony Pagliuca

3 UK STEM CELL STRATEGIC FORUM The future of unrelated donor SCT in the UK Antonio Pagliuca, Transplant Director King s College Hospital, London EBMT (UK) NAP GROUP 40 TH MEETING 30 th June 2011

4 Background The UK Stem Cell Strategic Forum was set up at the request of the Minister of State for Public Health in January 2010 To advise on future options for the provision and use of stem cells derived from unrelated adult volunteer donors and cord blood Also to be seen in the context of London Cancer Services: a proposed model of Care, commissioning models July 2010 Harmonisation of processes and costs The report, July 2010, was the result of three months of intensive effort by over forty scientists, clinicians, economists, and patient representatives

5 UK STEM CELL STRATEGIC FORUM Review areas The Healthcare Benefits of Unrelated Donor Haemopoietic Stem Cell Transplantation in the UK The Provision of Stem Cells for Transplantation in the UK Meeting the Demand for Stem Cells in the UK Increasing the Availability of Adult Donor Haemopoietic Stem Cells for Transplantation Increasing the Availability of Cord Blood Units for Transplantation Supply Chain Options for Improving the Availability of Donor Stem Cells in the UK Financial Appraisal of Options to Reconfigure the Supply Chains Health Economic Analysis The Commissioning of Unrelated Donor Stem Cell Transplantation in the UK The Value of Research and Development In Unrelated Donor Stem Cell Transplantation and Regenerative Medicine Performance Managing the Provision of Unrelated Donor Stem Cells for Transplantation Stakeholder Consultation

6 Global Distribution of Hematopoietic Stem Cell Transplantations (HSCTs) in 2006 Gratwohl, A. et al. JAMA 2010;303:

7 Macroeconomic Factors and Transplant Rates UK Transplant Rate per 10m inhabitants Team Density teams per 1m inhabitants Gratwohl, A. et al. JAMA 2010;303:

8 Unrelated donor HSCT trends worldwide.

9 The increasing use of unrelated donor HSCT in older patients

10 The increased use of cord blood in the UK for unrelated donor HSCT in adults

11 Types of stem cell donation transplanted by country and the use of cord blood in unrelated HSCT

12 Worldwide trends in the national and international provision of stem cell donations for HSCT

13 The proportion on stem cells sourced from UK and overseas donors

14 Distribution of ethnic minority individuals in the UK (UK Census data, April 2001) Key: 6.4% to 60.4% 2.5% to 6.3% 1.5% to 2.4% 1.0% to 1.4% 0.2% to 0.9%

15 Patient matching rates by ethnicity (2004/5)

16 Relationship between matching rate and size for large European donor registers

17 OUTCOMES

18

19 Rates and outcome of HSCT according to HDI Giebel S et al, Blood April 2010

20 UD UCBT CENTRE EFFECT DFS BY NUMBER OF TRANSPLANTS PERFORMED 1,0,8,6,4 > 10 transplants: 35 5% at 2 yr,2 P = < 10 transplants: 20 4% at 2 yr 0, Months Eurocord, unpublished.

21

22

23

24

25 Number of transplants Adult HSCT since 2004 UK only SIBLING UNRELATED CORD AUTO Centre

26 Number of transplants Adult Allografts since 2004 UK only in Descending Order TOTAL SIBLING UNRELATED CORD Centre

27 Geographic concentration of adult and paediatric transplant activity in the UK, 2009 ADULT PAEDIATRIC

28 Example of Commissioning Responsibilities Blood and Marrow Transplantation Responsible Party Non-specialised commissioners Specialised commissioners Non-specialised commissioners Pathway Elements All pre-transplant activity up to and including the point of decision to transplant Stem cell harvesting for patients for whom a definite decision to transplant has not been made Autograft Phases 1 to 4 Allograft Phases 0 to 6 and Donor Lymphocyte Infusion if appropriate All subsequent follow up activity following post transplant discharge EXCEPT where a new transplant package of care is instigated Commissioning Currency Routine activity funded at national tariff Locally determined tariffs for the package of care Routine activity funded at national tariff

29 Treatment Phases-Autograft AUTOGRAFT PHASE 1 -Decision to Transplant, Pre Transplant Mobilisation/ Stem Cell Harvest/Manipulation Storage &Pre Transplant Assessment PHASE 2 -Patient Work up inc disease assessment. PHASE 3 -TRANSPLANT ADMISSION / EPISODE - Conditioning regimen/management of Pancytopenic phase and regeneration. PHASE 4 -Discharge to 100 day follow up PHASE day to 1 Year follow up (not included in costing calculations)

30 Treatment Phases-Allograft ALLOGRAFT RELATED/UNRELATED PHASE 1 -Decision to Transplant, patient assessment, Investigations, Donor Matching /Selection / Testing / Tissue Typing PHASE 2 -Patient & Donor Work up PHASE 3 -Donor Harvest including Stem cell manipulation & may include provision of GCSF/ Patient work up etc PHASE 4 -TRANSPLANT ADMISSION Conditioning regimen & Stem cell infusion. Management of pancytopenic phase and Graft vs. Host disease. PHASE 5 -Occasional Requirement for repeat Stem Cell Infusion with / without Chemo if graft failure occurs

31 Treatment Phases-Allograft cont. PHASE 6 - Discharge to 100 day follow up including management of acute - graft versus host disease / infections and other complications PHASE days onwards, Management of Complex Issues; Graft vs. Host disease, secondary Malignancy, opportunistic Infections, excludes Donor Lymphocyte Infusions (not included in costing calculations) PHASE 8 - Donor Lymphocyte Infusions (not included in costing calculations)

32 Associated Tariffs- 2010/11 International Supplement BMT Type Cost model Tariff 10/11 ( ) Antifungal price per transplant Donor Tissue Typing Average cost per transplant Donor Costs Average cost per transplant Total price per transplant Autologous* 29,888 1,631 31,519 Allogeneic related Allogeneic unrelated 46,336 4,622 3, ,914 6,110 3, DLI 7, Example from London consortium with MFF

33 Funding Allocation Phases Autos Allo Related Allo Unrelated 1 17% 22% 3% 2 10% 5% 3% 3 63% 10% 9% 4 10% 48% 70% 5 No Data No Data 6 15% 15% 7 Example: If the charge covers only the period up to discharge then the following should be deducted from the prices in the earlier table, all other things being equal: Phase 4 for Auto (10%) Phase 6 for Allo (15%) Taken from Consortium Costing Model Guidelines Nov 2009

34 Proposed framework for commissioning and performance monitoring the provision of cord blood and adult donor stem cells for HSCT

35 The Findings Each year in the UK, about 170 Caucasian and 90 black and minority ethnic patients fail to locate a suitably matched adult donor. Around 110 patients with a matched donor die or deteriorate beyond transplantation while waiting to be transplanted. Improved access to adult unrelated donors and cord blood donations will cure around an additional 1000 people of an otherwise fatal condition over the next ten years

36 The Recommendations Adult Donors Greater engagement with black and minority ethnic donors Selected donors should be HLA typed to high resolution The UK should introduce predictive search technologies A graft identification advisory service should be established Increase contact with donors

37 The Recommendations Cord Blood The UK should increase its inventory of cord blood to 50,000 high dose units (8,000 currently at NHS-CBB). The inventory should contain 30% to 50% of donations from black and ethnic minority women (40% currently). Newly banked units should contain over 90 x 10 7 TNC (ethnic minority donors) or 120 x 10 7 TNC (Caucasian donors). High resolution HLA typing should be performed on newly stored units and selected existing units.

38 The Recommendations Transplantation Streamline registry activities in the UK Educate commissioners on patient outcomes Cord blood transplantation should be concentrated into designated Centres of Excellence Data collection and outcome monitoring should be integrated into every stage of the patient pathway Designated transplant centres should work together to support an alternative donor clinical trials network A Stem Cell Advisory Forum should build on the work and membership of the UK Stem Cell Strategic Forum

39 The Case for Investment Autumn 2010 Ministerial support for recommendations and a request for NHSBT and Anthony Nolan to develop a joint bid for funding. November business case requests 50.1m over 5 years. Proposal to: a) align NHSBT and Anthony Nolan registry activities b) bank 50,000 cord blood donations over 5 years c) improve provision of adult donors via high res. typing & matching algorithm Separately, NHSBT is: a) implementing operational improvements in BBMR b) implementing EMDIS (July go live) c) HLA DRB1 typing existing cord blood donations

40 Additional Funding of 4m for 2011/12 Ministerial announcement during January 2011 of 4m funding in first instance. NHSBT and Anthony Nolan proposing a collaborative framework which will see: UK transplant centres accessing NHSBT stem cell donors via the Anthony Nolan register Anthony Nolan and NHSBT ramping up cord blood collection and banking to 24/7 Anthony Nolan and NHSBT investing in high resolution typing of selected existing adult donors and cord blood donations pdf

Reference: NHS England B04/P/a

Reference: NHS England B04/P/a Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation (HSCT) (All Ages): Revised Reference: NHS England B04/P/a 1 NHS England Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation

More information

EUROCORD. in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases

EUROCORD. in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases ! 21%! EUROCORD 6756 cord blood transplantations performed from 1988 to March 2010 in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases * missing center

More information

Most Patients who Need an Allo Transplant Can Find a Well Matched Donor

Most Patients who Need an Allo Transplant Can Find a Well Matched Donor Most Patients who Need an Allo Transplant Can Find a Well Matched Donor Important Points: Most patients can find a well matched or a very well matched available adult donor in the Be The Match Registry.

More information

Blood and Marrow Transplantation Services and QIPP

Blood and Marrow Transplantation Services and QIPP Blood and Marrow Transplantation Services and QIPP Contents 1. Executive Summary 2. Background 2.1 What is QIPP? 2.2 BMT services the current picture 2.3 QIPP and BMT services 3. Main Themes 3.1 Clinical

More information

Hematopoietic Stem Cell Transplantation. Imad A. Tabbara, M.D. Professor of Medicine

Hematopoietic Stem Cell Transplantation. Imad A. Tabbara, M.D. Professor of Medicine Hematopoietic Stem Cell Transplantation Imad A. Tabbara, M.D. Professor of Medicine Hematopoietic Stem Cells Harvested from blood, bone marrow, umbilical cord blood Positive selection of CD34 (+) cells

More information

OUR JOURNEY THROUGH THE YEARS

OUR JOURNEY THROUGH THE YEARS The King Faisal Specialist Hospital and Research Centre Experience in Hematology, Oncology and Bone Marrow Transplantation OUR JOURNEY THROUGH THE YEARS REGGIE BELKHEDIM A Brief Overview: King Faisal Specialist

More information

UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE

UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE HIND AL HUMAIDAN, MD,FRCPA Director, Blood Bank (Donor & Transfusion Services) and Stem Cell Cord Blood Bank Consultant Hematopathologist INTRODUCTION

More information

Part 1 Findings and Recommendations

Part 1 Findings and Recommendations The Future of Unrelated Donor Stem Cell Transplantation in the UK Part 1 Findings and Recommendations A Report from the UK Stem Cell Strategic Forum July 2010 www.nhsbt.nhs.uk Foreword Haemopoietic stem

More information

Bone Marrow, Peripheral Blood Stem Cells or Umbilical Cord Blood transplantation? Federica Giannotti, MD Eurocord-Hôpital Saint Louis, Paris

Bone Marrow, Peripheral Blood Stem Cells or Umbilical Cord Blood transplantation? Federica Giannotti, MD Eurocord-Hôpital Saint Louis, Paris Bone Marrow, Peripheral Blood Stem Cells or Umbilical Cord Blood transplantation? Federica Giannotti, MD Eurocord-Hôpital Saint Louis, Paris Background Hematopoietic stem cell transplantation (HSCT) is

More information

Pr Eliane Gluckman, MD, FRCP, Disclosure of Interest: Nothing to Disclose

Pr Eliane Gluckman, MD, FRCP, Disclosure of Interest: Nothing to Disclose Pr Eliane Gluckman, MD, FRCP, Hospital Saint Louis, University Paris- Diderot, France Should Haplo-identical transplantation be preferred to cord blood in patients without a matched donor? Disclosure of

More information

Outcome of Unrelated HSCT in Patients Lacking HLA Matched Related Donors: Iranian Stem Cell Donor Program (ISCDP)

Outcome of Unrelated HSCT in Patients Lacking HLA Matched Related Donors: Iranian Stem Cell Donor Program (ISCDP) Outcome of Unrelated HSCT in Patients Lacking HLA Matched Related Donors: Iranian Stem Cell Donor Program (ISCDP) October 18, 2014 19th Congress of APBMT, Hangzhou, China AMIR ALI HAMIDIEH, MD Iranian

More information

Equality of Access to Transplant for Ethnic Minority Patients Through Use of Cord Blood and Haploidentical Transplants

Equality of Access to Transplant for Ethnic Minority Patients Through Use of Cord Blood and Haploidentical Transplants Equality of Access to Transplant for Ethnic Minority Patients Through Use of Cord Blood and Haploidentical Transplants Lown R.N., 1 Marsh S.G.E., 1 Blake H., 1 Evseeva I., 1 MacKinnon, S., 2 Pagliuca,

More information

How to select a donor and product for allogeneic HCT

How to select a donor and product for allogeneic HCT How to select a donor and product for allogeneic HCT Dr Bronwen Shaw 10 February 2015 Overview Who (and where) are the donors What factors determine how we choose between them Acquisition Clinical Donor

More information

Part 2 Annexes. www.nhsbt.nhs.uk. The Future of Unrelated Donor Stem Cell Transplantation in the UK

Part 2 Annexes. www.nhsbt.nhs.uk. The Future of Unrelated Donor Stem Cell Transplantation in the UK The Future of Unrelated Donor Stem Cell Transplantation in the UK Part 2 Annexes A Report from the UK Stem Cell Strategic Forum July 2010 www.nhsbt.nhs.uk Table of Contents Abbreviations... 6 Glossary...

More information

SEARCHING FOR A BONE MARROW DONOR

SEARCHING FOR A BONE MARROW DONOR SEARCHING FOR A BONE MARROW DONOR Angela received a bone marrow transplant from an unrelated donor to treat her non-hodgkin s lymphoma. INFORMATION FOR PATIENTS AND THEIR FAMILIES For patients who need

More information

International NetCord Foundation Executive Committee Conference Call Minutes May 23, 2007

International NetCord Foundation Executive Committee Conference Call Minutes May 23, 2007 International NetCord Foundation Executive Committee Conference Call Minutes Committee Members: Board Members: Staff: President Joan Garcia and Drs. Yves Beguin and Elizabeth Shpall Drs. Cristina Navarrete

More information

5. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.

5. All cord blood banks should be subject to the same standards, regulations and accreditation requirements. WMDA Policy Statement for the Utility of Autologous or Family Cord Blood Unit Storage (This policy statement has been approved and adopted by the WMDA board on the 25 th of May 2006) The Cord Blood Registries

More information

Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood

Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood [Track 2: What Is a Transplant?] Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood can be an effective treatment for people with blood cancers such as leukemia,

More information

Pros and Cons of Stem Cell Sources and their availability in Africa. Dr Jaimendra Singh Inkosi Albert Luthuli Central Hospital Durban, South Africa

Pros and Cons of Stem Cell Sources and their availability in Africa. Dr Jaimendra Singh Inkosi Albert Luthuli Central Hospital Durban, South Africa Pros and Cons of Stem Cell Sources and their availability in Africa Dr Jaimendra Singh Inkosi Albert Luthuli Central Hospital Durban, South Africa Introduction The ability to perform a haematopoietic stem

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for CLL and SLL File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_for_cll_and_sll

More information

The donor search: the best donor or cord blood unit

The donor search: the best donor or cord blood unit The donor search: the best donor or cord blood unit Dr Bronwen Shaw Consultant in haematopoietic cell transplantation Royal Marsden Hospital /Anthony Nolan Overview Where do we find donors/units for transplantation

More information

INFORMATION ON STEM CELLS/BONE MARROW AND REINFUSION/TRANSPLANTATION SUR703.002

INFORMATION ON STEM CELLS/BONE MARROW AND REINFUSION/TRANSPLANTATION SUR703.002 INFORMATION ON STEM CELLS/BONE MARROW AND REINFUSION/TRANSPLANTATION SUR703.002 COVERAGE: SPECIAL COMMENT ON POLICY REVIEW: Due to the complexity of the Peripheral and Bone Marrow Stem Cell Transplantation

More information

Umbilical Cord Blood Transplantation

Umbilical Cord Blood Transplantation Umbilical Cord Blood Transplantation V Rocha MD, PhD Hopital Saint Louis, Paris University 7 CIBMTR Milwaukee Umbilical Cord blood transplantation Background History Clinical results in children and adults

More information

Corporate Medical Policy Cord Blood as a Source of Stem Cells

Corporate Medical Policy Cord Blood as a Source of Stem Cells Corporate Medical Policy Cord Blood as a Source of Stem Cells File Name: Origination: Last CAP Review: Next CAP Review: Last Review cord_blood_as_a_source_of_stem_cells 2/2001 3/2015 3/2016 3/2015 Description

More information

Corporate Medical Policy Cord Blood as a Source of Stem Cells

Corporate Medical Policy Cord Blood as a Source of Stem Cells Corporate Medical Policy Cord Blood as a Source of Stem Cells File Name: Origination: Last CAP Review: Next CAP Review: Last Review cord_blood_as_a_source_of_stem_cells 2/2001 3/2015 3/2016 3/2015 Description

More information

Blood cells are vital to the human body

Blood cells are vital to the human body Candide FONT-SALA Blood cells are vital to the human body Red cells transport oxygen From http://www.english-online.at/biology/blood/blood-supply-and-blood-diseases.htm Red cell life span 120 days 200

More information

The Danish Bone Marrow Donor Registry DBMDR

The Danish Bone Marrow Donor Registry DBMDR The DBMDR Vision To achieve and maintain a position as an internationally recognized hematopoietic stem cell donor registry with respect to high quality of donor data base and HLA typing, individualized,

More information

Umbilical Cord Blood Stem Cells Current Status & Future Potential

Umbilical Cord Blood Stem Cells Current Status & Future Potential Umbilical Cord Blood Stem Cells Current Status & Future Potential Natasha Ali Assistant Professor Haematology Department of Pathology & Laboratory Medicine/Oncology The Aga Khan University Email: natasha.ali@aku.edu

More information

Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for Breast Cancer

Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for Breast Cancer Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for Breast Cancer File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem_cell_transplantation_for_breast_cancer

More information

A fact sheet UNRELATED BONE MARROW AND CORD BLOOD STEM CELL TRANSPLANTS

A fact sheet UNRELATED BONE MARROW AND CORD BLOOD STEM CELL TRANSPLANTS A fact sheet UNRELATED BONE MARROW AND CORD BLOOD STEM CELL TRANSPLANTS Each year, thousands of patients are diagnosed with diseases treatable by a blood stem cell transplant. These blood stem cells can

More information

Data Reporting Problems

Data Reporting Problems Data Reporting Problems Shelley Hewerdine & Khrystyna Valkiv Istanbul, 23rd March 2015 #EBMT2015 www.ebmt.org Format of this session Recent EBMT Registry work Improving Data Quality Data reporting Quiz

More information

Directed/Related Cord Blood Collection by NHS Blood and Transplant

Directed/Related Cord Blood Collection by NHS Blood and Transplant Directed/Related Cord Blood Collection by Jacqui Thompson Clinical Scientist Section Head of Specialist Procedures Stem Cells and Immunotherapies Department National Blood Service, NHSBT Birmingham Why

More information

4. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.

4. All cord blood banks should be subject to the same standards, regulations and accreditation requirements. WMDA Policy Statement on the Utility of Autologous or Family Cord Blood Unit Storage The WMDA Board adopted this policy on 25 th of May 2006. Policy updated _April 2011 The Cord Blood Working Group and

More information

10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program. Thursday, June 7

10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program. Thursday, June 7 10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program Thursday, June 7 7:00 8:00 AM Breakfast in Exhibit Hall Session IA 8:00 10:00 AM Advances in

More information

Unrelated Donor Stem Cell Transplantation in the UK

Unrelated Donor Stem Cell Transplantation in the UK Unrelated Donor Stem Cell Transplantation in the UK Effective Affordable Sustainable A Report from the UK Stem Cell Strategy Oversight Committee November 2014 www.nhsbt.nhs.uk Contents Introduction 3

More information

P R E S S K I T 2013 TABLE OF CONTENTS. About the European Group for Blood and Marrow Transplantation

P R E S S K I T 2013 TABLE OF CONTENTS. About the European Group for Blood and Marrow Transplantation TABLE OF CONTENTS About the European Group for Blood and Marrow Transplantation Haematopoietic Stem Cell Transplantation (HSCT): Key facts & figures EBMT Data - A foundation for cutting-edge research Clinical

More information

On April 4, a group of physicians at the 37th annual

On April 4, a group of physicians at the 37th annual By Ronale Tucker Rhodes, MS Better gene sampling and newer transplant regimens are making stem cell transplantation possible for a host of disease states that previously were rarely considered for this

More information

Public Cord Blood Tissue Bank Committee on Health Care Services and Representative Peaden

Public Cord Blood Tissue Bank Committee on Health Care Services and Representative Peaden HOUSE OF REPRESENTATIVES COMMITTEE ON HEALTH CARE SERVICES ANALYSIS BILL #: HB 2337 (PCB HCS 00-07) RELATING TO: SPONSOR(S): TIED BILL(S): Public Cord Blood Tissue Bank Committee on Health Care Services

More information

A Public Cord Blood Bank for South Africa? i

A Public Cord Blood Bank for South Africa? i No. 42/2007 A Public Cord Blood Bank for South Africa? i By Dr Robert Crookes MBChB (Wits), Dip. Internal Medicine (American Board of Internal Medicine, USA) Transfusion Medicine Consultant. South African

More information

OPERATIONS USER GUIDE

OPERATIONS USER GUIDE OPERATIONS USER GUIDE 1 Ver 1.3 (06/12) CONTENTS 1 Background and organisation of Anthony Nolan 3 2 Patients for whom a search may be requested 5 3 Procedure for requesting HLA testing and a search 6 4

More information

Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation. April 2013. Reference: NHSCB/B04/P/a

Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation. April 2013. Reference: NHSCB/B04/P/a Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation April 2013 Reference: NHS Commissioning Board Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation First published:

More information

SAVING LIVES: ACHIEVING MORE

SAVING LIVES: ACHIEVING MORE SAVING LIVES: ACHIEVING MORE Anthony Nolan Organisational strategy for 2015-2018 Where we re coming from In 1974, we were the world s first stem cell donor register. And over 40 years later, we re at the

More information

Do you have anything to add? If so, I d love to hear from you! Jessica Robinson Conference Manager Life Sciences @jessbiopharma

Do you have anything to add? If so, I d love to hear from you! Jessica Robinson Conference Manager Life Sciences @jessbiopharma 1 Who is the most influential figure in cord blood around the world? What is the biggest challenge to overcome in the use of cord blood as a source of stem cells? We asked 10 leading experts in the cord

More information

Cord blood banking: information for parents

Cord blood banking: information for parents Cord blood banking: information for parents Published August 2006 by the RCOG Contents Page number Key points 1 About this information 2 What is cord blood? 2 Why is cord blood useful? 3 How is cord blood

More information

Navelstrengbloed tegen kanker

Navelstrengbloed tegen kanker Navelstrengbloed tegen kanker THERAPIEDAG 2008: "Zorgtrajecten in kanker" Zaterdag 27 september 2008 Gasthuisberg, Leuven. Hélène Schoemans, MD KUL, Stem Cell Institute Leuven Cord blood Collection and

More information

Laura Machin, Lancaster Medical School, UK Takuya Matsushige, National Institute of Public Health, Japan Richard Williams, Management Science,

Laura Machin, Lancaster Medical School, UK Takuya Matsushige, National Institute of Public Health, Japan Richard Williams, Management Science, Laura Machin, Lancaster Medical School, UK Takuya Matsushige, National Institute of Public Health, Japan Richard Williams, Management Science, Lancaster University, UK Today Exploring Perceptions of 'Quality'

More information

CPT Codes for Bone Marrow Transplant January 2015 James L. Gajewski, MD

CPT Codes for Bone Marrow Transplant January 2015 James L. Gajewski, MD The blood and marrow transplant field has 15 dedicated CPT codes. These CPT codes can be categorized into three groups: 1. Collection Codes 2. Cell Processing Codes 3. Cell Infusion Codes Collection Codes

More information

STEM CELLS FROM THE UMBLICAL CORD BLOOD AND UMBLICAL CORD TISSUE

STEM CELLS FROM THE UMBLICAL CORD BLOOD AND UMBLICAL CORD TISSUE STEM CELLS FROM THE UMBLICAL CORD BLOOD AND UMBLICAL CORD TISSUE What are Stem Cells? Stem cells are the basic building blocks of all the cells, tissues and organs in the human body. The role of the stem

More information

Cord Blood Bank Business Plan

Cord Blood Bank Business Plan Cord Blood Bank Business Plan A sample of how to create a new program Produced by the AABB subsection: Cellular Therapy Business Management with major contributions by Nicole Omer TABLE OF CONTENTS Page

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_for_epithelial_ovarian_cancer 2/2001 11/2015 11/2016 11/2015 Description

More information

Bone Marrow Transplantation and Peripheral Blood Stem Cell Transplantation: Questions and Answers. Key Points

Bone Marrow Transplantation and Peripheral Blood Stem Cell Transplantation: Questions and Answers. Key Points CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Bone Marrow Transplantation

More information

Improving Quality in Cellular Therapy with FACT Accreditation. The Foundation for the Accreditation of Cellular Therapy

Improving Quality in Cellular Therapy with FACT Accreditation. The Foundation for the Accreditation of Cellular Therapy Improving Quality in Cellular Therapy with FACT Accreditation The Foundation for the Accreditation of Cellular Therapy 1 Goals and Services of FACT Promote quality patient care and laboratory practice

More information

Title: SECTION 7.0 NZBMDR STANDARDS PROCESS FOR DONOR IDENTIFICATION

Title: SECTION 7.0 NZBMDR STANDARDS PROCESS FOR DONOR IDENTIFICATION NZBMDRGuidelines-007.10 Date Effective: 01/05/2010 Page 1 Title: SECTION 7.0 NZBMDR STANDARDS PROCESS FOR DONOR IDENTIFICATION Authorised by: Executive Officer Contributing Authors: ABMDR Scientific Expert

More information

What is a Stem Cell Transplantation?

What is a Stem Cell Transplantation? What is a Stem Cell Transplantation? Guest Expert: Stuart, MD Associate Professor, Medical Oncology www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with Drs. Ed and Ken. I am

More information

Arriving at a better future for people with blood cancer

Arriving at a better future for people with blood cancer Arriving at a better future for people with blood cancer CONTENTS Foreword 1 Part One 2 Part Two 4 Statistics 7 Part Three 11 Conclusion 13 Acknowledgements 14 Foreword We re looking ahead to a future

More information

DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT

DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT www.narayanahealth.org DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT About Narayana Health City Narayana Health, one of India's largest and the world's most economical healthcare service providers

More information

Cord Blood Stem Cell Transplantation

Cord Blood Stem Cell Transplantation LEUKEMIA LYMPHOMA MYELOMA FACTS Cord Blood Stem Cell Transplantation No. 2 in a series providing the latest information on blood cancers Highlights Umbilical cord blood, like bone marrow and peripheral

More information

Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for Breast Cancer

Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for Breast Cancer Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for Breast Cancer File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem_cell_transplantation_for_breast_cancer

More information

The Value of Cord Blood Stem Cells. Mona Shafey, MD, FRCPC Medical Grand Rounds October 25 th, 2011

The Value of Cord Blood Stem Cells. Mona Shafey, MD, FRCPC Medical Grand Rounds October 25 th, 2011 The Value of Cord Blood Stem Cells Mona Shafey, MD, FRCPC Medical Grand Rounds October 25 th, 2011 Objectives To discuss umbilical cord blood as a stem cell source and the role of umbilical cord blood

More information

Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease

Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease 1 Produced by St. Jude Children s Research Hospital Departments of Hematology, Patient

More information

Selecting an appropriately matched donor for hematopoietic

Selecting an appropriately matched donor for hematopoietic Transplant Outcomes in Acute Leukemia (I) Mary Eapen a and John E. Wagner b Umbilical cord blood (UCB) has gradually emerged over the last decade as an alternative source of hematopoietic cells for transplantation

More information

Cord Blood: that other stem cell source. Donna Wall, MD Director, Manitoba Blood and Marrow Transplant Program

Cord Blood: that other stem cell source. Donna Wall, MD Director, Manitoba Blood and Marrow Transplant Program Cord Blood: that other stem cell source Donna Wall, MD Director, Manitoba Blood and Marrow Transplant Program CBMTG April 2012 The problem: In order to perform a BMT from one person to another one needs

More information

Milano Cord Blood Bank 18 year report on cord blood banking and transplant

Milano Cord Blood Bank 18 year report on cord blood banking and transplant Milano Cord Blood Bank 18 year report on cord blood banking and transplant Paolo Rebulla, MD Milano Cord Blood Bank Center of Transfusion Medicine, Cellular Therapy and Cryobiology Department of Regenerative

More information

Donate your baby s cord blood and save lives.

Donate your baby s cord blood and save lives. Donate your baby s cord blood and save lives. A public nonprofit cord blood bank licensed by the FDA Each year, thousands of people are diagnosed with life-threatening diseases that may be cured with a

More information

CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION

CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION Chapter 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION 1.1 OVERVIEW OF THE CORD BLOOD TRANSPLANTATION STUDY Bone marrow transplantation

More information

Economics of Cord Blood Banking. Michael Boo NMDP Be The Match September 11, 2015

Economics of Cord Blood Banking. Michael Boo NMDP Be The Match September 11, 2015 Economics of Cord Blood Banking Michael Boo NMDP Be The Match September 11, 2015 Historical Use UCB Use Data 2 NMDP Historical Transplants by Product 7,000 6,500 6,000 5,500 5,000 4,500 4,000 3,500 3,000

More information

Canadian Blood Services National Public Cord Blood Bank Give Life Twice Transfusion Medicine Residents

Canadian Blood Services National Public Cord Blood Bank Give Life Twice Transfusion Medicine Residents Canadian Blood Services National Public Cord Blood Bank Give Life Twice Transfusion Medicine Residents Eileen Quinlan Collection Supervisor, Brampton (GTA) 2015-11-10 History One Match Stem Cell and Marrow

More information

cord blood 4-1-1230, Off Abids Road, Bogulkunta, Hyderabad 500001. 3-6-282, Opp. Old MLA Qrtrs., Hyderguda, Hyderabad 500029.

cord blood 4-1-1230, Off Abids Road, Bogulkunta, Hyderabad 500001. 3-6-282, Opp. Old MLA Qrtrs., Hyderguda, Hyderabad 500029. Department of Obstetrics cord blood UNIT 1 BOGULKUNTA 4-1-1230, Off Abids Road, Bogulkunta, Hyderabad 500001. UNIT 2 HYDERGUDA 3-6-282, Opp. Old MLA Qrtrs., Hyderguda, Hyderabad 500029. UNIT 3 JUBILEE

More information

Summary of Advisory Council on Blood Stem Cell Transplantation: Recommendations and Status

Summary of Advisory Council on Blood Stem Cell Transplantation: Recommendations and Status of Advisory Council on Blood Stem Cell Transplantation: Recommendations and Shelley Grant Branch Chief, Blood Stem Cell Transplantation Program September 11, 2015 Overview December 20, 2005 - HRSA began

More information

Before your child has a stem cell transplant (SCT)

Before your child has a stem cell transplant (SCT) Before your child has a stem cell transplant (SCT) A guide for families The information contained within this leaflet is the property of Imperial College London Healthcare NHS Trust. Introduction This

More information

H. R. 2107 IN THE HOUSE OF REPRESENTATIVES

H. R. 2107 IN THE HOUSE OF REPRESENTATIVES I 1TH CONGRESS 1ST SESSION H. R. 2107 To direct the Secretary of Health and Human Services to conduct a public education campaign on umbilical cord blood stem cells, and for other purposes. IN THE HOUSE

More information

Cellular Therapy and Cord Blood Market Report 2013 Page 1. Kathy Gray Worldwide Market Reports & Consulting Coordinator Select Biosciences

Cellular Therapy and Cord Blood Market Report 2013 Page 1. Kathy Gray Worldwide Market Reports & Consulting Coordinator Select Biosciences Cellular Therapy and Cord Blood Market Report 2013 Kathy Gray Worldwide Market Reports & Consulting Coordinator Select Biosciences k.gray@selectbio.com Select Biosciences Market Reports Website: SelectBiosciences.com/marketreports/

More information

New Zealand Bone Marrow Donor Registry

New Zealand Bone Marrow Donor Registry Title: Authorised by: SECTION 9.0 NZBMDR STANDARDS PROCESS FOR AN UNRELATED STEM CELL DONOR WORKUP & IDENTIFICATION OF CORD BLOOD UNITS Executive Officer Contributing Authors: Sally Gordon Dr Hilary Blacklock

More information

Helping you find the one match.. Guide for Unrelated Stem Cell Transplant Patients OneMatch Stem Cell and Marrow Network BLOOD.

Helping you find the one match.. Guide for Unrelated Stem Cell Transplant Patients OneMatch Stem Cell and Marrow Network BLOOD. Helping you find the one match.. Guide for Unrelated Stem Cell Transplant Patients OneMatch Stem Cell and Marrow Network BLOOD.CA WWW This guide is intended for patients in need of an unrelated volunteer

More information

The Anthony Nolan and NHS Stem Cell Registry Annual Review 2014

The Anthony Nolan and NHS Stem Cell Registry Annual Review 2014 The Anthony Nolan and NHS Stem Cell Registry Annual Review 2014 1 CONTENTS The very first State of the Registry review showcases the work, achievements and impact of the alignment of all the UK registers

More information

Triennial Review of NHS Blood and Transplant (NHSBT) A Review of NHS Blood and Transplant (NHSBT) Call for Evidence

Triennial Review of NHS Blood and Transplant (NHSBT) A Review of NHS Blood and Transplant (NHSBT) Call for Evidence Triennial Review of NHS Blood and Transplant (NHSBT) A Review of NHS Blood and Transplant (NHSBT) Call for Evidence August 2015 Title: Triennial Review of NHS Blood and Transplant Call for Evidence Author:

More information

Stem Cell Background Paper

Stem Cell Background Paper Stem Cell Background Paper Introduction...2 Stem Cell Basics...3 Stem Cell Process Flow...9 Comparison of Blood, Stem Cells, Tissues and Organs Processes...10 Responsibilities for the Blood, Stem Cells,

More information

Cellular Therapy and Cord Blood 2013 Market Report

Cellular Therapy and Cord Blood 2013 Market Report Brochure More information from http://www.researchandmarkets.com/reports/2393891/ Cellular Therapy and Cord Blood 2013 Market Report Description: This is the most up-to-date market report focusing on Cellular

More information

NEWS RELEASE. For Immediate Release. For more information, please contact:

NEWS RELEASE. For Immediate Release. For more information, please contact: NEWS RELEASE For Immediate Release For more information, please contact: Charlene Han Singapore Cord Blood Bank Tel: (65) 6394-5017 charlene.han.j.j@scbb.com.sg Singapore Cord Blood Bank records 21 st

More information

Blood-Forming Stem Cell Transplants

Blood-Forming Stem Cell Transplants Blood-Forming Stem Cell Transplants What are bone marrow and hematopoietic stem cells? Bone marrow is the soft, sponge-like material found inside bones. It contains immature cells known as hematopoietic

More information

Cord Cor Blood Banking Scott N. Furlan, MD Ellen S. Plummer, Plummer MD

Cord Cor Blood Banking Scott N. Furlan, MD Ellen S. Plummer, Plummer MD Cord Blood Banking Scott N. Furlan, MD Ellen S.Plummer, MD Overview Background Biology of Stem Cell Transplant Opportunities i at Parkland Logistics of Banking Potential Barriers Indications for HCT Cancer

More information

Cord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape

Cord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape GENReports: Market & Tech Analysis Cord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape > Enal Razvi, Ph.D. Biotechnology Analyst, Managing Director SELECTBIO US enal@selectbio.us

More information

Infosheet. Allogeneic stem cell transplantation in myeloma. What is the principle behind stem cell transplantation?

Infosheet. Allogeneic stem cell transplantation in myeloma. What is the principle behind stem cell transplantation? Infosheet Allogeneic stem cell transplantation in myeloma High-dose therapy and autologous stem cell transplantation is currently the first-line treatment standard of care for younger/fitter myeloma patients.

More information

SAVE A LIFE... BY GIVING LIFE!

SAVE A LIFE... BY GIVING LIFE! SAVE A LIFE... BY GIVING LIFE! FOLLOW US ON: HÉMA-QUÉBEC PUBLIC CORD BLOOD BANK www.hema-quebec.qc.ca Scan this code with your smart phone to access the page Register to the Public Cord Blood Bank on the

More information

Disclosures. I have no disclosures.

Disclosures. I have no disclosures. Not Your Own Marrow Jenni Krajewski, MD Clinical Assistant Professor, Rutgers New Jersey Medical School Attending Physician, Pediatric Blood and Marrow Transplantation The Institute for Pediatric Cancer

More information

Stem Cell Transplantation and the Canadian First Nations Community. Becky Luk (PTLS) Tanya Petraszko, MD

Stem Cell Transplantation and the Canadian First Nations Community. Becky Luk (PTLS) Tanya Petraszko, MD Stem Cell Transplantation and the Canadian First Nations Community Becky Luk (PTLS) Tanya Petraszko, MD Why is there a need for stem cells? Our Story Why are we engaging the First Nations, Metis and Inuit

More information

A Cure for Sickle Cell Anemia and Thalassemia

A Cure for Sickle Cell Anemia and Thalassemia IV Simpósio Internacional de Hemoglobinopatias A Cure for Sickle Cell Anemia and Thalassemia Bertram Lubin, MD and Mark Walters, MD 4 September 2007 Topics to be covered Cord blood: Importance and biology

More information

STEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA

STEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA STEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA OVO CLINIC I 8000 BLVD DECARIE, MONTREAL QC H4P 2S4 I 514.798.2000 I OVOCLINIC.COM 2 a therapeutic revolution As the

More information

Selection of the Optimal Umbilical Cord Blood Unit

Selection of the Optimal Umbilical Cord Blood Unit Karen Ballen, MD Selection of the Optimal Umbilical Cord Blood Unit Massachusetts General Hospital September, 2013 OUTLINE Cell Dose HLA Match Allele Level HLA C KIR Directional Mismatch NIMA HLA Antibodies

More information

Q: Why is there a need for people to join the Be The Match Registry?

Q: Why is there a need for people to join the Be The Match Registry? Q: Why is there a need for people to join the Be The Match Registry? A: Thousands of patients with blood cancers like leukemia and lymphoma, sickle cell and other life-threatening diseases depend on the

More information

The Business of Cellular Therapy and Hematopoietic Stem Cell Transplantation

The Business of Cellular Therapy and Hematopoietic Stem Cell Transplantation CHAPTER 2 The Business of Cellular Therapy and Hematopoietic Stem Cell Transplantation Peggy Appel and Richard T. Maziarz Hematopoietic stem cell transplant (HSCT) is a complex process that is associated

More information

Bone Marrow Transplant Services in New Zealand for Adults

Bone Marrow Transplant Services in New Zealand for Adults Bone Marrow Transplant Services in New Zealand for Adults Citation: Ministry of Health. 2011. Bone Marrow Transplant Services in New Zealand for Adults Service Improvement Plan. Wellington: Ministry of

More information

Challenges of Hematopoietic Stem Cell Transplantation. Robert J. Soiffer, MD Dana Farber Cancer Institute

Challenges of Hematopoietic Stem Cell Transplantation. Robert J. Soiffer, MD Dana Farber Cancer Institute Challenges of Hematopoietic Stem Cell Transplantation Robert J. Soiffer, MD Dana Farber Cancer Institute Hematopoietic Stem Cell Transplantation Objectives Deliver sufficient chemo-radio therapy to destroy

More information

Cord blood for the treatment of acute lymphoblastic leukemia in young children

Cord blood for the treatment of acute lymphoblastic leukemia in young children Cord blood for the treatment of acute lymphoblastic leukemia in young children By Caitlin McGreevy Kiara Paramjothy Pass with Merit RESEARCH PAPER BASED ON PATHOLOGY LECTURES AT MEDLINK 2011 1 Abstract:

More information

30 June 2014 Non Promise users. Dear Data Manager RE: DATA QUALITY CHECKS WE NEED YOUR HELP PLEASE!

30 June 2014 Non Promise users. Dear Data Manager RE: DATA QUALITY CHECKS WE NEED YOUR HELP PLEASE! 30 June 2014 Non Promise users Dear Data Manager RE: DATA QUALITY CHECKS WE NEED YOUR HELP PLEASE! I am contacting you to ask for your assistance in checking your centre s data before it is transferred

More information

GAO NATIONAL CORD BLOOD INVENTORY. Practices for Increasing Availability for Transplants and Related Challenges. Report to Congressional Committees

GAO NATIONAL CORD BLOOD INVENTORY. Practices for Increasing Availability for Transplants and Related Challenges. Report to Congressional Committees GAO United States Government Accountability Office Report to Congressional Committees October 2011 NATIONAL CORD BLOOD INVENTORY Practices for Increasing Availability for Transplants and Related Challenges

More information

WBMT Global Survey. Helen Baldomero Cape Town November 2014. Worldwide Network for Blood and Marrow Transplantation

WBMT Global Survey. Helen Baldomero Cape Town November 2014. Worldwide Network for Blood and Marrow Transplantation WBMT Global Survey Helen Baldomero Cape Town November 214 NGO in official relations with World Health Organization Leukemias LPD Solid tumors Non - Malignant disorders NGO in official relations with World

More information

Graft Failure After HSCT

Graft Failure After HSCT Graft Failure After HSCT Vanderson Rocha, MD, PhD Professor of Haematology- Oxford University Bone Marrow Transplant Unit- Sirio Libanes Hospital- Sao Paulo Scientific Director of Eurocord-Paris Clinical

More information

UMBILICAL CORD BLOOD HARVESTING & STORAGE

UMBILICAL CORD BLOOD HARVESTING & STORAGE Protocol: TRP009 Effective Date: October 14, 2013 UMBILICAL CORD BLOOD HARVESTING & STORAGE Table of Contents Page COMMERCIAL, MEDICARE & MEDICAID COVERAGE RATIONALE... 1 BACKGROUND... 2 CLINICAL EVIDENCE...

More information

Kathie Viers-City of Hope Eric Presson- Baylor Health Care Systems Jennifer Christian-Markay Cancer Center

Kathie Viers-City of Hope Eric Presson- Baylor Health Care Systems Jennifer Christian-Markay Cancer Center Kathie Viers-City of Hope Eric Presson- Baylor Health Care Systems Jennifer Christian-Markay Cancer Center Discuss Quality dashboards as auditing and Reporting Methods for Quality Management Provide examples

More information